LSTA Lisata Therapeutics, Inc.

NASDAQ
$1.58

Lisata Therapeutics, Inc. (LSTA) is expected to report earnings on November 9, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +41.1% since its last earnings release on August 6, 2026.

Lisata Therapeutics Reported Earnings
Thursday, August 6, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.60

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Lisata Therapeutics, Inc.

Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.